XML 55 R42.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
May 18, 2020
May 07, 2020
Nov. 30, 2016
May 25, 2016
Jun. 18, 2009
Sep. 30, 2020
May 31, 2019
Dec. 31, 2018
Oct. 31, 2018
Aug. 31, 2020
May 31, 2020
May 31, 2019
May 28, 2020
Dec. 31, 2019
Sep. 25, 2019
Jul. 22, 2019
Jul. 12, 2019
Jan. 31, 2018
Nov. 30, 2017
Sep. 30, 2017
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Research and Development Expense                     $ 1,910,209 $ 1,679,098                
MEXICO                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Operating Leases, Rent Expense                     43,481 46,040                
UNITED STATES                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Operating Leases, Rent Expense                     300,267 268,550                
EZ Detect Product [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Contract Term               12 months 3 years                      
Other Nonoperating Expense                     0 27,579                
EZ Detect Product [Member] | Minimum [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Success Fees Percentage               2.50%                        
EZ Detect Product [Member] | Maximum [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Success Fees Percentage               6.00%                        
Non-exclusive Distributor Agreement [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Contract Term 2 years                                      
Building In Irvine California [Member] | First Amendment To Lease [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Lease Expiration Date         Aug. 31, 2021                              
Operating Leases, Rent Expense, Minimum Rentals         $ 21,000                              
Rental Expense, Increase During Period         23,637                              
Operating Leases, Rent Expense         22,948                              
Lease Deposit Liability         $ 22,080                              
Property Available for Operating Lease [Member] | MEXICO                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Operating Leases, Rent Expense, Minimum Rentals     $ 2,926                                  
Operating Leases, Rent Expense     $ 3,239                                  
Lease Expiration Period     10 years                                  
MaxHealth [Member] | EZ Detect Product [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Related Party Transaction, Purchases from Related Party             $ 100,000                          
Related Party Transaction, Due from (to) Related Party             900,000         900,000                
Related Party Transaction, Amounts of Transaction             $ 1,000,000                          
Related Party Transaction, Description of Transaction             The $1,000,000 was to be used as a prepayment for the first $1,000,000 of purchase orders for the product. While the Company received the first deposit of $100,000, and shipped $100,000 of product to Maxhealth, the Company has not received the second deposit, and has not shipped any further product, which has placed MaxHealth in Default of the agreement                          
University OF Michigan [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Clinical Trial Agreement Maximum Budgeted Costs                                     $ 181,015  
Research and Development Expense                     $ 30,900 40,885                
Billed Commitment, Percentage                     47.00%                  
Deaconess Medical Center [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Clinical Trial Agreement Maximum Budgeted Costs                     $ 305,000             $ 142,000    
Research and Development Expense                     141,640 146,760                
Research Management Institution [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Clinical Trial Agreement Maximum Budgeted Costs                                 $ 117,200      
Research and Development Expense                     13,111                  
Other Accrued Liabilities, Current                     6,670                  
Biomerica Infoods Product [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Clinical Trial Agreement Maximum Budgeted Costs                               $ 107,000        
Research and Development Expense                     $ 20,875                  
Billed Commitment, Percentage                     19.00%                  
Accrued Liabilities, Current                     $ 2,650                  
Biomerica Infoods IBS Product [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Clinical Trial Agreement Maximum Budgeted Costs                             $ 136,000          
Research and Development Expense                     $ 45,250                  
Billed Commitment, Percentage                     33.00%                  
Accrued Liabilities, Current                     $ 5,975                  
Biomerica H. Pylori Product [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Clinical Trial Agreement Maximum Budgeted Costs                             $ 57,800          
Research and Development Expense                     $ 41,845                  
Billed Commitment, Percentage                     72.00%                  
Houston Methodist Research Institute [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Clinical Trial Agreement Maximum Budgeted Costs                           $ 133,000            
Research and Development Expense                     $ 4,000                  
Billed Commitment, Percentage                     3.00%                  
Mayo Clinic Arizona [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Clinical Trial Agreement Maximum Budgeted Costs                         $ 135,515              
Research and Development Expense                     $ 17,390                  
Billed Commitment, Percentage                     13.00%                  
Mayo Clinic Jacksonville [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Clinical Trial Agreement Maximum Budgeted Costs                         $ 135,515              
Research and Development Expense                     $ 17,390                  
Royalty Agreements [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Royalty Expense                     $ 15,000 $ 19,000                
Royalty Agreements [Member] | Revenue Benchmark [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Royalty Expense Percentage Of Sales                     1.80% 2.90%                
Telcon Agreement [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Accrued Fees and Other Revenue Receivable       $ 1,250,000                                
Stock Issued During Period, Shares, Other (in Shares)       83,333                                
Proceeds from Fees Received       $ 250,000                                
Royalty Percentage       15.00%                                
Mount Sinai License Agreements [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Related Party Transaction, Purchases from Related Party                     $ 5,100                  
Mount Sinai License Agreements [Member] | Subsequent Event [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Related Party Transaction, Purchases from Related Party                   $ 2,850                    
UC License Agreements [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Payments for Other Fees   $ 5,000                                    
License Maintenance Fee, Payable                     10,000                  
UC License Agreements [Member] | Subsequent Event [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Payments for Other Fees           $ 5,000                            
University Of Southern California [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Accrued Fees and Other Revenue Receivable                     17,064                  
Clinical Trial Agreement Maximum Budgeted Costs                                       $ 82,472
Research and Development Expense                     2,200                  
Other Research and Development Expense                     12,567                  
University Of Southern California [Member] | Maximum [Member]                                        
COMMITMENTS AND CONTINGENCIES (Details) [Line Items]                                        
Research and Development Expense                     $ 14,767